Clinical Trial Update: An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection

View source ↗

Summary

This document reports an expanded-access study of the oral liquid form of efavirenz for children with HIV infection. The trial is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Sustiva (efavirenz) (efavirenz)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infection | Status: NO_LONGER_AVAILABLE